RxDoctor Payments Data

Bill Lawrence, MD

Family Medicine · Conway, ARNPI 1154344810

Payments from drug & device makers

$3,361in general payments, 2019–2025

Across 205 payments — averaging $16.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$377
  • Novo Nordisk$371
  • Amgen$255
  • Lilly USA, LLC$235
  • AstraZeneca$215
  • AbbVie$187
  • plus $2K from 35 others

What the payments were for

  • Food & beverage$3,361100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,361 in reported general payments places this provider in the 80th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$318,433
Medicare patients
507
Services billed
4,227

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide185$238,635
MounjaroTirzepatide53$64,183
EliquisApixaban76$52,541
FarxigaDapagliflozin Propanediol36$37,909
JardianceEmpagliflozin29$32,084
Trelegy ElliptaFluticasone/Umeclidin/Vilanter25$23,288
LinzessLinaclotide21$19,249
Tresiba Flextouch U-200Insulin Degludec17$19,203
AbrysvoRsv Vacc, Pref A And Pref B/Pf57$18,272
Tresiba Flextouch U-100Insulin Degludec15$15,687
EntrestoSacubitril/Valsartan16$14,655
XareltoRivaroxaban12$14,504
TrulicityDulaglutide12$11,890
ShingrixVaricella-Zoster Ge/As01b/Pf48$10,614
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog19$10,055

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$371$238,635185 claims
Lilly USA, LLCMounjaro, Trulicity$235$76,07365 claims
PfizerEliquis, Abrysvo, Premarin$377$72,945144 claims
AstraZenecaFarxiga$215$37,90936 claims
GSKTrelegy Ellipta, Shingrix$81$33,90273 claims
Boehringer IngelheimJardiance$97$32,08429 claims
AbbVieLinzess$187$19,24921 claims
NovartisEntresto$14$14,65516 claims
Johnson & JohnsonXarelto$128$14,50412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Conway

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →